Of all the clinical devices a patient may use at home, the pulse oximeter is the most widespread, the cheapest, and the most frequently misused. The ubiquity of sub-₹1,000 fingertip oximeters in the Indian market since 2020 has put a device into millions of homes that was previously confined to clinical settings — and many of those households have not been taught how to use it properly. An inaccurate reading misleads in both directions: a falsely reassuring 96% when the patient is actually hypoxaemic; a falsely alarming 88% when peripheral perfusion is the issue and the true saturation is 95%. This article lays out the correct technique for using a pulse oximeter, the confounders that produce spurious readings, the accuracy bands of different device classes, the specific limitations relevant to Indian skin tones and household habits, and when a home reading should prompt action versus when it should prompt a more careful second reading.
The audience: patients and families using home oximeters for chronic disease monitoring (COPD, ILD, post-COVID, sleep apnoea screening), primary-care staff interpreting home-reported readings, and the increasing number of clinicians who receive SpO₂ numbers from patients via phone, WhatsApp, or tele-consultation and must decide what to do with them.
How a pulse oximeter actually works
A pulse oximeter shines two wavelengths of light — red (~660 nm) and infrared (~940 nm) — through a tissue bed, typically a fingertip. Oxyhaemoglobin and deoxyhaemoglobin absorb each wavelength differently: oxyhaemoglobin absorbs more infrared and less red; deoxyhaemoglobin absorbs more red and less infrared. The device measures the ratio of pulsatile absorbance at the two wavelengths (R/IR ratio), applies a calibration curve derived from healthy-volunteer desaturation studies, and reports SpO₂ as a percentage.
The pulsatile component is critical. The device ignores steady-state absorbance (bone, connective tissue, venous blood) and only samples the component that pulses with each heartbeat — which is, by definition, arterial. This is why the device also reports a pulse rate; if the pulse signal is weak or absent, the SpO₂ reading is unreliable regardless of whether a number appears on the screen.
Two implications:
-
Good peripheral perfusion is required. Cold hands, vasoconstriction, peripheral vascular disease, and shock all reduce the pulsatile signal. The device may still display a number but the error bars are much wider.
-
The calibration is empirical. The R/IR-to-SpO₂ conversion comes from desaturation studies in healthy volunteers. Below SpO₂ 70%, the extrapolation is less reliable because few volunteers are desaturated that deeply in calibration studies. Between 70% and 95%, the conversion is well-validated; above 95%, the response is flat and small changes are hard to distinguish.
Correct technique: placement and environment
The textbook procedure for a reliable home SpO₂ reading:
1. Warm the hands. Cold hands produce peripheral vasoconstriction and a low perfusion index. If the hands feel cool, run warm water over them for 30–60 seconds, or briskly rub them together, before placing the oximeter.
2. Remove nail polish, artificial nails, and fresh henna from the finger being used. Dark nail polish (black, navy, dark red, dark green) absorbs the oximeter’s light and can produce falsely low readings; metallic and glitter polishes can produce unpredictable errors. Artificial nails are opaque and interfere with transmission. Fresh henna (Mehndi) — common in Indian households, particularly before weddings and festivals — applies a layer of dye that variably affects transmission; the effect is less pronounced than thick nail polish but is not negligible.
If polish or henna cannot be removed, place the sensor sideways across the finger (so the light passes through the finger pad perpendicular to the direction of the nail) or use a different digit (typically the ring finger or little finger, which are less likely to have polish on them in many cases).
3. Choose an appropriate finger. The index or middle finger of the non-dominant hand is the convention. Avoid fingers with recent trauma, swelling, oedema, or obvious peripheral vascular compromise. For patients with chronic conditions affecting peripheral circulation (diabetes with peripheral neuropathy and vascular disease, scleroderma, Raynaud’s), the ear lobe is often a more reliable site if an earlobe oximeter is available.
4. Place the finger fully into the sensor. The fingertip should reach the end of the sensor chamber; if the finger is inserted only partway, the light path is incorrect and the reading is unreliable. Most fingertip oximeters are sized for average adult fingers; very small fingers (children, some elderly patients) may need a pediatric-sized device.
5. Rest the hand at heart level. A hand held below the heart pools venous blood and can produce falsely low readings. A hand held high above the heart reduces perfusion and can also confound. Resting on a table or in the lap, at approximately heart level, is standard.
6. Stay still. Movement (shivering, tremor, speaking, adjusting posture) corrupts the pulse waveform. Clinical-grade devices with signal-extraction technology tolerate some motion; most consumer devices do not. Remain still for at least 15–30 seconds before taking the reading.
7. Wait for the reading to stabilise. The first 10–20 seconds after placement show fluctuating values as the device acquires the pulse signal. Wait until the number stabilises — it should not be jumping by more than 1–2 percentage points per second. A properly stabilised reading has been displayed consistently for at least 30 seconds.
8. Record the reading and the pulse rate. Both numbers. A plausibly normal SpO₂ with an implausible pulse rate (e.g., SpO₂ 96%, pulse 33 when the patient’s actual pulse is 90) means the device is not tracking the real arterial pulse and the SpO₂ number is suspect.
9. Check the perfusion index if available. Some oximeters display a perfusion index (PI). A PI above 1.0 is good; below 0.4 indicates poor peripheral perfusion and the reading should be interpreted cautiously or retaken after warming the hand.
10. Retake the reading if the situation is clinically important and the first reading is unexpected. Multiple readings across two or three fingers, spaced a minute apart, are more reliable than a single spot-check.
Confounders and their magnitude
Cold peripheries. A commonly under-appreciated source of falsely low SpO₂. In cold-climate locations (Himalayan states, Punjab and Haryana in winter), patients routinely report SpO₂ in the mid-80s in the morning with no clinical symptoms; warming the hand typically returns the reading to a normal range. The error from poor perfusion is typically 3–8 percentage points on the low side.
Nail polish and henna. Errors from 2–5 percentage points, usually on the low side. Dark and metallic polishes are worst; light polishes (pink, nude) produce smaller errors.
Carboxyhaemoglobinaemia. Smokers (15+ cigarettes/day) often have chronic COHb of 3–8%. Victims of acute CO exposure (household fire, faulty gas geyser, charcoal burning in an enclosed space, which remains a seasonal risk in Indian winters) can have COHb of 15–40%. Pulse oximetry reads COHb as O₂Hb; SpO₂ appears reassuring while the patient is severely hypoxic. Any suspicion of CO exposure means the SpO₂ number cannot be trusted and ABG with co-oximetry is mandatory.
Methaemoglobinaemia. Pulse oximetry readings converge toward ~85% regardless of true saturation. Dapsone exposure, topical anaesthetics, certain aniline dyes (textile industry), amyl nitrite, and G6PD deficiency with oxidative stress are the main Indian-relevant causes.
Intravenous dye. Methylene blue and indocyanine green (used in some diagnostic procedures) can produce transient falsely low SpO₂ readings for minutes to tens of minutes post-administration.
Skin pigmentation. The systematic over-reading of SpO₂ in darker-skinned patients, documented in the North American literature post-2020, is under-studied in Indian cohorts but the mechanism implies applicability. Indian skin tones span Fitzpatrick IV–VI; the effect is that a reading of 92% on a home oximeter may correspond to a true SaO₂ of 88–90% in some patients. The magnitude depends on the specific device’s calibration dataset; clinical-grade oximeters with broad validation datasets (Masimo, Nonin) perform better than generic consumer devices.
Motion artefact. Shivering, tremor, or movement during reading can produce errors of several percentage points in either direction. Parkinson’s tremor, cerebellar tremor, and essential tremor all degrade consumer-grade oximeter readings meaningfully.
Tricuspid regurgitation. Severe TR with prominent venous pulsations in the finger can cause the device to sample venous blood as if it were arterial, producing falsely low readings.
Bright ambient light. Some devices are sensitive to fluorescent or direct sunlight on the sensor; shielding the sensor with a hand during the reading addresses this.
Anaemia. Profound anaemia (Hb <5 g/dL) can produce mildly depressed SpO₂ readings; the effect is small in the common clinical range.
Accuracy bands: consumer vs clinical devices
The ISO 80601-2-61 standard for pulse oximeters specifies root-mean-square error (ARMS) requirements, typically ≤3% in the 70–100% SpO₂ range for devices that comply. Not all devices on the Indian market claim or meet ISO compliance.
Clinical-grade devices (Masimo Rad-series, Nellcor PM10N/OxiMax, Nonin handhelds, Edwards handhelds, GE and Philips bedside monitors) typically meet ISO 80601-2-61, are validated in desaturation studies across skin tones, and have ARMS ≤2% under typical conditions. These devices are expensive (₹15,000–₹60,000+) and concentrated in hospital, ICU, and tertiary pulmonology settings. Some home-care service providers also deploy them for critical patients.
Mid-range consumer devices from reputable manufacturers (Nonin GO2, iHealth, Beurer, Omron, some ChoiceMMed models) typically claim ISO compliance, are reasonably validated, and sit in the ₹3,000–₹10,000 range. Accuracy is typically ARMS 2–3%, with more error at low saturations and in poor perfusion conditions.
Budget consumer devices in the Indian market below ₹1,000 are a mixed bag. Some claim ISO compliance; verification of these claims is inconsistent. Regulatory oversight (CDSCO’s medical device regulation, applicable to pulse oximeters since 2020) has lagged the explosion of devices on the market. Accuracy for many is adequate for healthy users at normal saturations but degrades rapidly with lower perfusion, movement, or lower saturations. The unbranded ₹500 device a family uses to monitor a chronic-COPD patient may have ARMS of 4–6% — meaning a displayed SpO₂ of 90% could correspond to a true SaO₂ anywhere in the range 84–96%.
The practical implication: for chronic disease monitoring where readings guide real decisions, a mid-range device with a named manufacturer and documented ISO compliance is a reasonable investment. For casual household use where a reading occasionally prompts a clinical question rather than directly guiding therapy, the budget devices are adequate with the caveat that any surprising reading deserves a second opinion from a better device.
When to act on a home reading
A framework for patients and families:
SpO₂ 95% or above on room air: reassuring in most circumstances. No immediate action; continue with usual care. If the patient’s baseline is lower (e.g., high-altitude residence, severe chronic lung disease on LTOT), compare to personal baseline.
SpO₂ 91–94% on room air: possibly normal, possibly borderline. Retake after warming hands, using a different finger, and resting quietly for two minutes. If repeatedly 91–94% with no symptoms, discuss at next scheduled clinic visit. If the patient has chronic lung disease and their baseline is known to be above this, report to the treating physician.
SpO₂ 88–90% on room air: action-requiring. In a patient with known chronic lung disease on LTOT, this may be acceptable for the rest state but suggests the patient should be on their prescribed oxygen. In a patient not on oxygen, this range is hypoxaemic and should prompt clinical review within 24–48 hours.
SpO₂ <88% on room air: urgently action-requiring. Prompt the patient to start supplemental oxygen if prescribed, and seek medical review the same day. For a patient with no prior hypoxaemia diagnosis, SpO₂ <88% is hospital-territory unless rapidly corrected.
Any SpO₂ reading accompanied by severe symptoms (chest pain, altered mental status, severe dyspnoea, cyanosis) requires emergency evaluation regardless of the number.
The important framing: a home SpO₂ reading is a piece of information, not a diagnosis. It combines with symptoms, context, and clinical history to produce a decision. A single surprising number is a reason to take a second, more careful reading; a consistently abnormal trend over multiple readings is a reason to consult the treating physician.
The Indian consumer oximeter market
Post-2020, the Indian pulse-oximeter market expanded dramatically. Hundreds of brands distribute fingertip oximeters through e-commerce, pharmacy chains, and direct-to-consumer channels. The regulatory picture:
- CDSCO regulation began classifying pulse oximeters as medical devices from 2020 onwards, requiring manufacturers/importers to register and meet safety standards. Enforcement has been variable; grey-market and uncertified devices continue to reach consumers.
- Standards. ISO 80601-2-61 is the applicable standard. Compliance claims on device packaging are not always independently verifiable.
- Traceability. Many budget devices carry no manufacturer address, no registration number, and no calibration documentation. Replacement parts and service are effectively unavailable.
For a patient relying on home SpO₂ for chronic disease management, pragmatic recommendations:
- Buy from a named manufacturer with a verifiable Indian presence and a real customer service path. Beurer, Omron, Nonin, Masimo MightySat (premium), and ChoiceMMed are examples of broadly recognised brands.
- Verify against a clinical device at least once. At a pulmonology or primary care clinic visit, ask to compare a home reading against the clinic’s device under controlled conditions. A deviation of more than 2 percentage points warrants a replacement.
- Replace the battery and clean the sensor per the manufacturer’s instructions. Many budget devices fail silently when batteries are low or the sensor window is dirty.
- Track trends, not spot values. A patient who reads 93% most mornings and one day reads 88% has a meaningful signal; a patient who has never established a baseline cannot interpret a 88% reading.
- Do not rely on a single device for a life-critical decision. If a reading would change therapy materially, a second device or a clinical measurement is appropriate.
Consult your treating physician about what baseline SpO₂ you should expect to see at home and what readings should prompt a call — personalised thresholds are much more useful than population-wide cut-offs.
Closing: precision at the bedside
The pulse oximeter is arguably the most democratising piece of medical equipment in the modern era — a device that puts a core vital sign into every household, cheaply and non-invasively. Its very ubiquity, however, produces a false sense of precision: a number on a screen feels more authoritative than a symptom report. The reality is more nuanced. A good-quality oximeter, used correctly, in a patient with adequate peripheral perfusion, produces a reading within ±2 percentage points of the true arterial saturation. A poor-quality device, used on a cold finger with fresh henna, in a patient with tremor and mild anaemia, may produce a reading 8 or more percentage points off.
Technique matters. Device selection matters. Interpretation in context matters. The patient who understands all three gets more value from their oximeter than the one who treats it as an oracle. For the clinician receiving home SpO₂ reports by phone or tele-consultation, asking about the measurement conditions is not pedantry; it is basic clinical practice.
Primary references that inform clinical practice in this area: ISO 80601-2-61; US FDA Safety Communication 2022 on pulse oximeter limitations; Sjoding et al. NEJM 2020; WHO guidance on pulse oximetry in clinical settings; CDSCO medical device rules 2017 and amendments.